These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7202121)

  • 1. Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.
    Pollick C
    N Engl J Med; 1982 Oct; 307(16):997-9. PubMed ID: 7202121
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term propranolol therapy in muscular subaortic stenosis.
    Adelman AG; Shah PM; Gramiak R; Wigle ED
    Br Heart J; 1970 Nov; 32(6):804-11. PubMed ID: 5212354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of patients with idiopathic hypertrophic subaortic stenosis].
    Zatushevskii IF
    Ter Arkh; 1982; 54(1):122-8. PubMed ID: 6123157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
    Terrosu P; Franceschino V; Contini GM; Dore L; Ibba GV
    G Ital Cardiol; 1984 Jan; 14(1):63-6. PubMed ID: 6538527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fixed subaortic stenosis: clinical development and hemodynamic evaluation of surgical treatment].
    Maroto C; García EJ; Maroto E; Duarte J
    Rev Esp Cardiol; 1984; 37(3):181-5. PubMed ID: 6542245
    [No Abstract]   [Full Text] [Related]  

  • 8. [Obstructive cardiomyopathy of the left ventricle: prolonged treatment using beta-blockers. Haemodynamic, cineangiocardiographic and echographic study (author's transl)].
    Roudaut R; Page A; Bricaud H; Dallocchio M; Besse P
    Nouv Presse Med; 1979 Jun; 8(27):2286. PubMed ID: 40184
    [No Abstract]   [Full Text] [Related]  

  • 9. [2-dimensional echocardiography in fixed fibrous subaortic stenosis. Correlation with hemodynamics and M-mode echocardiography].
    Rodríguez-López AM; Huerta D; Velasco P; Guadalajara J; Esquivel J; Lara R; De los Ríos M; Gil M
    Arch Inst Cardiol Mex; 1984; 54(1):11-9. PubMed ID: 6539103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
    Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Idiopathic hypertrophic subaortic stenosis].
    Mukharliamov NM; Zatushevskiĭ IF; Dorofeeva ZZ
    Ter Arkh; 1980; 52(7):18-25. PubMed ID: 7190741
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Obstructive cardiomyopathy with idiopathic hypertrophic subaortic stenosis in the pediatric age].
    Pilotti G; Burzio P; Favetta S; Ricci C; Pennacino G
    Minerva Med; 1979 Nov; 70(48):3299-307. PubMed ID: 574624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
    Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
    Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J
    J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 19. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.
    Pollick C
    Am J Cardiol; 1988 Dec; 62(17):1252-5. PubMed ID: 3057852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.